Hereditary Spastic Paraplegia Type 5
1 clinical trials · Condition
◉ Watch Hereditary Spastic Paraplegia Type 5
| Record | Firm | Date |
|---|---|---|
| PCSK9 Inhibitor Treatment for Patients With SPG5 (NCT04101643) | First Affiliated Hospital of Fujian Medical University | 2019-09-29 |
Track Hereditary Spastic Paraplegia Type 5 automatically
Every clearance here is in the API, with alerts when new ones post.